DVI INC
10-Q, 2000-11-13
FINANCE LESSORS
Previous: SAZTEC INTERNATIONAL INC, 10-Q, EX-27, 2000-11-13
Next: DVI INC, 10-Q, EX-27, 2000-11-13

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 


FORM 10-Q

 
(Mark One)
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2000

  OR

o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                                        to                                   .
 
      Commission File Number:  0-16271
 
 DVI, INC.
  (Exact name of registrant as specified in its charter)
 
Delaware
   22-2722773
(State or other jurisdiction of    (I.R.S. Employer 
incorporation or organization)    Identification No.)
     
2500 York Road
Jamison, Pennsylvania

   18929
(Address of principal executive offices)    (Zip Code) 
 
Registrant’s telephone number, including area code: (215) 488-5000
 
          Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes  x  No   ¨
 
          Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
 
Common stock, $.005 par value—14,278,804 shares as of October 31, 2000.

 
DVI, INC. AND SUBSIDIARIES
 
INDEX
 
         Page
Number

PART I. FINANCIAL INFORMATION:  
 
Item 1. Financial Statements:     
 
  Consolidated Balance Sheets - September 30, 2000 (unaudited) and June 30, 2000      3-4
 
  Consolidated Statements of Operations (unaudited) - Three months ended September 30, 2000 and 1999      5
 
  Consolidated Statements of Shareholders’ Equity (unaudited) - June 30, 1999 through September 30, 2000      6
 
  Consolidated Statements of Cash Flows (unaudited) - Three months ended September 30, 2000 and 1999      7-8
 
  Notes to Consolidated Financial Statements (unaudited)      9-15
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations      15-17
 
Item 3. Quantitative and Qualitative Disclosures About Market Risk      18-28
 
PART II. OTHER INFORMATION 29
 
Signatures 30  
 

 

 

 
DVI, Inc. and Subsidiaries
 
Consolidated Balance Sheets
 
                                                        Assets
 
(in thousands of dollars except share data)
     September 30,
2000

     June 30,
2000

       (Unaudited)       
Cash and cash equivalents      $        5,928        $        6,353  
Restricted cash and cash equivalents      130,847        73,691  
Accounts receivable      33,633        36,818  
Investments      39,948        10,116  
Contract receivables:          
     Investment in direct financing leases and notes secured by equipment or medical
        receivables:
         
          Receivables in installments      906,911        898,063  
          Receivables and notes—related parties      5,754        5,782  
          Recourse credit enhancements      46,850        43,222  
          Net notes collateralized by medical receivables      229,929        252,974  
          Residual valuation      41,092        40,271  
          Unearned income      (110,928 )      (112,167 )
     
     
  
     Net investment in direct financing leases and notes secured by equipment or
        medical receivables
     1,119,608        1,128,145  
     Less: Allowance for losses on receivables      (17,397 )      (14,307 )
     
     
  
Net contract receivables      1,102,211        1,113,838  

Equipment on operating leases (net of accumulated depreciation of $10,628 and
     $9,155, respectively)

     29,043        29,385  
Repossessed assets      19,914        18,624  
Furniture and fixtures (net of accumulated depreciation of $5,665 and $5,261,      respectively)      5,453        4,670  
Goodwill, net      9,343        9,649  
Other assets      32,649        30,640  
     
     
  
Total assets      $1,408,969        $1,333,784  
     
     
  
 
The accompanying notes are an integral part of these consolidated financial statements.

 

 
DVI, Inc. and Subsidiaries
 
Consolidated Balance Sheets, continued
 
Liabilities and Shareholders’ Equity
(in thousands of dollars except share data)
     September 30,
2000

     June 30,
2000

       (Unaudited)       
Accounts payable      $      54,617        $      64,036  
Accrued expenses and other liabilities      28,267        24,749  
Borrowings under warehouse facilities      373,799        306,610  
Long-term debt:          
          Discounted receivables (primarily limited recourse)      450,940        424,759  
          9 7 /8% Senior notes due 2004
     155,000        155,000  
          Other debt      67,800        71,168  
          Convertible subordinated notes      13,900        13,900  
     
     
  
Total long-term debt      687,640        664,827  
     
     
  
 
Deferred income taxes      38,119        50,414  
Total liabilities      1,182,442        1,110,636  
Minority interest in consolidated subsidiaries      7,402        7,785  
Shareholders’ equity:          
          Preferred stock, $10.00 par value; authorized 100,000 shares; no shares
          issued
         
          Common stock, $.005 par value; authorized 25,000,000 shares;
          outstanding 14,228,804 and 14,222,974 shares, respectively
     71        71  
          Additional capital      135,465        135,346  
          Retained earnings      88,979        82,497  
          Accumulated other comprehensive loss      (5,390 )      (2,551 )
     
     
  
Total shareholders’ equity      219,125        215,363  
     
     
  
Total liabilities and shareholders’ equity      $1,408,969        $1,333,784  
     
     
  
 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
DVI, Inc. and Subsidiaries
 
Consolidated Statements of Operations (unaudited)
 
       Three Months Ended
September 30,

(in thousands of dollars except share data)
     2000
     1999
Finance and other income:          
          Amortization of finance income      $30,843        $24,388
          Other income      17,003        7,482
     
     
Total finance and other income      47,846        31,870
Interest expense      23,224        17,909
     
     
Net interest and other income      24,622        13,961
Net gain on sale of financing transactions      3,977        7,201
     
     
Net operating income      28,599        21,162
Selling, general and administrative expenses      12,452        8,732
Provision for losses on receivables      4,115        2,757
     
     
Earnings before minority interest, equity in net loss of investees, and provision
    for income taxes
     12,032        9,673
Minority interest in net loss of consolidated subsidiaries      360        133
Equity in net loss of investees      (18 )     
Provision for income taxes      5,892        4,234
     
     
Net earnings      $  6,482        $  5,572
     
     
Net earnings per share:
          Basic      $    0.46        $    0.39
     
     
          Diluted      $    0.42        $    0.37
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
 
DVI, Inc. and Subsidiaries
 
Consolidated Statements of Shareholders’ Equity (unaudited)
 
       Common Stock
$.005 Par Value

     Additional
Capital

     Retained
Earnings

     Accumulated
Other
Comprehensive
Loss

     Total
Shareholders’
Equity

(in thousands of dollars except share data)
     Shares
     Amount
Balances at June 30, 1999      14,168,608      $71      $134,610      $59,055      $(2,089 )      $191,647  
          Net earnings                     23,442           23,442  
          Unrealized loss on available-
               for-sale securities (net of
              deferred taxes of $70)
                         (105 )      (105 )
          Currency translation adjustment                          (357 )      (357 )
                                      
  
              Comprehensive income                               22,980  
          Issuance of common stock upon
               exercise of stock options and
               warrants
     54,366           690                690  
          Non-employee stock option grants                46                46  
     
  
  
  
  
     
  
Balances at June 30, 2000      14,222,974      71      135,346      82,497      (2,551 )      215,363  
          Net earnings                     6,482           6,482  
          Unrealized loss on available-
               for-sale securities (net of
               deferred taxes of $9)
                         (14 )      (14 )
          Unrealized loss on derivative
               instruments designated as
               cash flow hedges (net of
               deferred taxes of $1,103)
                         (1,650 )      (1,650 )
          Currency translation adjustment                          (1,175 )      (1,175 )
                                      
  
              Comprehensive income                               3,643  
          Issuance of common stock upon
               exercise of stock options and
               warrants
     5,830             85                85  
          Non-employee stock option grants                34                34  
     
  
  
  
  
     
  
Balances at September 30, 2000      14,228,804      $71      $135,465      $88,979      $(5,390 )      $219,125  
     
  
  
  
  
     
  
 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
 
 
DVI, Inc. and Subsidiaries
 
Consolidated Statements of Cash Flows (unaudited)
 
       Three Months Ended
September 30,

(in thousands of dollars)
     2000
     1999
Cash flows from operating activities:          
     Net earnings      $    6,482        $    5,572  
     
     
  
     Adjustments to reconcile net earnings to net cash used in operating activities:          
     Equity in net loss of investees      18         
     Depreciation and amortization      5,958        5,156  
     Provision for losses on receivables      4,115        2,757  
     Net gain on sale of financing transactions      (3,977 )      (7,201 )
     Minority interest in net loss of consolidated subsidiaries      (360 )      (133 )
     Unrealized gain on investments      (14,881 )       
     Cumulative translation adjustments      (1,175 )      1,609  
     Deferred income taxes      (12,286 )       
     Changes in assets and liabilities:          
     (Increases) decreases in:          
                    Restricted cash and cash equivalents      (57,156 )      (14,338 )
                    Accounts receivable      1,442        (1,365 )
                    Other assets      (5,093 )      (328 )
     Increases (decreases) in:          
                    Accounts payable      13,048        6,678  
                    Accrued expenses and other liabilities      1,867        (2,694 )
     
     
  
     Total adjustments      (68,480 )      (9,859 )
     
     
  
     Net cash used in operating activities      (61,998 )      (4,287 )
     
     
  
Cash flows from investing activities:          
     Receivables originated or purchased      (186,025 )      (216,549 )
     Portfolio receipts net of amounts included in income and proceeds from sale of
         financing transactions
     145,157        157,033  
     Net decrease (increase) in notes collateralized by medical receivables      13,569        (31,264 )
     Furniture and fixtures additions      (1,215 )      (264 )
     
     
  
     Net cash used in investing activities      (28,514 )      (91,044 )
     
     
  
Cash flows from financing activities:          
     Exercise of stock options and warrants      85        468  
     Borrowings under warehouse facilities, net of repayments      67,189        59,768  
     Borrowings under long-term debt      64,554        77,691  
     Repayments on long-term debt      (41,741 )      (39,673 )
     
     
  
     Net cash provided by financing activities      90,087        98,254  
     
     
  
 
continued
 
 
DVI, Inc. and Subsidiaries
 
Consolidated Statements of Cash Flows (unaudited) (concluded)
 
(in thousands of dollars)
     Three Months Ended
September 30,

     2000
     1999
Net (decrease) increase in cash and cash equivalents      $    (425 )      $  2,923  
Cash and cash equivalents, beginning of period      6,353        5,695  
       
       
  
Cash and cash equivalents, end of period      $  5,928        $  8,618  
       
       
  
Cash paid (received) during the period for:          
          Interest      $22,908        $18,591  
       
       
  
          Income taxes, net of refunds      $     183        $      (34 )
       
       
  
 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
Notes to Consolidated Financial Statements (unaudited)
 
In this discussion, the terms “DVI”, the “Company”, “we”, “us” and “our” refer to DVI, Inc. and its subsidiaries, except where it is made clear that such terms mean only DVI, Inc. or an individual subsidiary.
 
Note 1.    Basis of Presentation
 
The accompanying consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles (GAAP) for complete financial statements. The consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in our latest annual report on Form 10-K for the fiscal year ended June 30, 2000.
 
In the opinion of management, the consolidated financial statements contain all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the consolidated balance sheets as of September 30, 2000 and June 30, 2000, the consolidated statements of operations for the three month periods ended September 30, 2000 and 1999, the consolidated statements of shareholders’ equity for the period from June 30, 1999 through September 30, 2000, and the consolidated statements of cash flows for the three month periods ended September 30, 2000 and 1999. The results of operations for the three month period ended September 30, 2000 are not necessarily indicative of the results of operations to be expected for the fiscal year ending June 30, 2001.
 
Certain amounts as previously reported have been reclassified to conform to the presentation for the three month period ended September 30, 2000.
 
Note 2.    Recent Accounting Developments
 
In June 1998, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards (“SFAS”) No. 133, Accounting for Derivative Instruments and Hedging Activities. This statement establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. SFAS No. 133, as amended, is effective for all quarters of fiscal years beginning after June 15, 2000 and does not permit retroactive restatement of prior period financial statements. This statement requires the recognition of all derivative instruments as either assets or liabilities in the statement of financial position measured at fair value. Generally, increases or decreases in the fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If certain conditions are met, where the derivative instrument has been designated as a fair value hedge, the hedged item will also be marked to market through earnings thus creating an offset. If the derivative is designated and qualifies as a cash flow hedge, the changes in fair value of the derivative instrument will be recorded in Other comprehensive income. If the derivative is designated as a hedge of a net investment in foreign operations, changes in fair value of the derivative will be recorded as cumulative translation adjustments.
 

On July 1, 2000, we adopted SFAS 133. The recognition of the fair value of all freestanding derivative instruments resulted in recording liabilities in the amount of $260,000. The transition adjustment for derivatives in cash flow hedges was to record a liability of $380,000 and was recognized as a cumulative-effect-type adjustment in accumulated other comprehensive income. The transition adjustment for derivatives in fair value hedges was to record an asset of $56,000 and was recognized as a cumulative-effect-type adjustment to net income. This adjustment was offset by the adjustment of the carrying value of the hedged assets. The transition adjustment for derivatives in hedges of net investments in foreign operations was to record a liability of $88,000 and was recognized as a cumulative-effect-type adjustment in cumulative translation adjustments.

The majority of our assets and liabilities are financial contracts with fixed and variable rates. Any mismatch between the repricing and maturity characteristics of our assets and liabilities exposes us to interest rate risk when interest rates fluctuate. To manage our interest rate risk, we employ a hedging strategy using derivative financial instruments.

 

 
Our equipment loans are structured and permanently funded on a fixed-rate basis, but we use warehouse facilities until the permanent funding is obtained. Since funds borrowed through these warehouse facilities are obtained on a floating-rate basis, we are exposed to a certain degree of risk if interest rates rise and increase our borrowing costs. We manage this exposure through interest rate swaps or interest rate caps whereby we effectively change the variable borrowing cost to a fixed borrowing cost. These types of hedges are considered cash flow hedges.
 
In addition, when we originate equipment loans, we base our pricing in part on the spread we expect to achieve between the interest rate we charge our equipment loan customers and the effective interest cost we will pay when we permanently fund those loans, usually through securitization. Increases in interest rates that increase our permanent funding costs between the time the loans are originated and the time they are securitized could narrow, eliminate or even reverse this spread. We manage this exposure through the use of Treasury locks and forward start interest rate swaps to effectively fix the benchmark-pricing index of our forecasted securitization transactions. These types of hedges are considered cash flow hedges.
 
Changes in the interest rates affect the fair value of fixed rate assets and liabilities. In a rising interest rate environment, fixed rate assets lose market value whereas fixed rate liabilities gain market value and vice versa. We manage our fixed rate asset exposure to fair value changes through the use of interest rate swaps whereby we attempt to limit the change in their fair value by effectively changing the benchmark pricing index from a fixed rate to a floating rate. These types of hedges are considered fair value hedges.
 
At September 30, 2000, we held the following derivative positions to manage our interest rate risk:
 
(in thousands of dollars)
     Notional
Amount

     Fair
Value

 
Cash Flow Hedges:
         
Options      $  90,000.0      $      77.3  
Treasury locks      50,000.0      (979.0 )
Interest rate swaps       272,821.3       (1,705.4 )
 
Fair Value Hedges:
         
Interest rate swaps      $  10,537.8      $      32.0  
 
In the next twelve months, we are forecasting to complete two securitizations. When these securitizations are completed, the fair value adjustments in Other comprehensive income will be reclassified into earnings and will be offset through the securitization closing entries, including adjustments to the gain on sale. If the fair value of the hedges is negative, the actual securitization pricing is lower than our hedged rate, which fixes our effective borrowing cost at our hedged rate. If the fair value of the hedges is positive, the actual securitization pricing is higher than our hedged rate, which also fixes our effective borrowing cost at our hedged rate. When the forecasted securitizations close, we currently expect $2.1 million in fair value adjustments to be reclassified from Other comprehensive income into earnings.

The maximum length of time that we are hedging the exposure of our future cash flows for forecasted transactions is through November 2, 2003.

We have foreign currency exposures in our international operations due to lending in some areas in local currencies that are not funded with local currency borrowings but with U.S. dollars. In order to limit our exposure to foreign currency movements, we employ a hedging strategy using derivative instruments, primarily forward sales of the appropriate foreign currency. These types of hedges are considered net investment in foreign operations hedges.

 

 
At September 30, 2000, we held the following derivative positions to manage our foreign currency exposure:
 
(in thousands of dollars)
     Notional
Amount

     Fair
Value

 
Net Investment in Foreign Operations Hedges:
         
Foreign currency denominated forward rate agreements      $11,311.1      $(61.1 )
 
There was $844,000 in gains included in cumulative translation adjustments during the quarter ended September 30, 2000, which includes the July 1, 2000 transition adjustment loss of $88,000.
 
Before entering into a derivative transaction for hedging purposes, we determine that a high degree of initial effectiveness exists between the change in the value of the hedged item and the change in the value of the derivative from a movement in interest rates or foreign currency rates, as applicable. High effectiveness means that the change in the value of the derivative will effectively offset the change in the value of the hedged item. We measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness as defined by FASB 133 is recognized in the income statement. When options are used for hedging, the time value of the option is excluded from this effectiveness assessment. At September 30, 2000, there was a decline in fair value of $10,069 due to hedge ineffectiveness on cash flow hedges. This decrease was recognized in Other income.

Accumulated Derivative Loss
 
The following table summarizes activity in Other comprehensive income related to derivatives classified as cash flow hedges that we held during the period covering July 1, 2000 (the date of our adoption of SFAS 133) through September 30, 2000:
 
(in thousands of dollars, net of deferred taxes)
Cumulative effect of adopting SFAS 133 as of July 1, 2000 (transition
  adjustment)
     $    (228 )
(Gains)/losses reclassified into earnings       
Change in fair value of derivatives       (1,422 )
       
  
          Accumulated derivative loss included in Other comprehensive income
            as of September 30, 2000
     $ (1,650 )
       
  
 
Note 3.   Allowance for Losses on Receivables
 
The following is an analysis of the allowance for losses on receivables:
 
(in thousands of dollars)
     Three Months Ended
September 30,

     2000
     1999
Balance, beginning of period      $14,307        $12,279  
Provision for losses on receivables      4,115        2,757  
Provision for losses on recourse credit enhancements      749         
Net charge-offs      (1,774 )      (1,516 )
       
       
  
          Balance, end of period      $17,397        $13,520  
       
       
  

 

 
Note 4.    Corvis Corporation Warrants
 
Beginning in July 1999, we made certain loans to Corvis Corporation (Nasdaq: CORV) for which we received warrants that will allow us to acquire an aggregate of 737,900 shares of Corvis common stock at a price of $0.76 per share. There is a 180-day lock-up on the exercise of these warrants that prohibits us from selling or otherwise disposing of them before January 24, 2001. This provision affects the warrants’ liquidity, and as a result the warrants we hold are accorded a lower value than similar securities without such a transferability restriction. We have had the fair market value of the warrants periodically updated by an independent professional appraiser to reflect the price at which they would change hands between willing buyers and sellers subject to the lock-up provision. Based on the effective accounting literature at June 30, 2000, we recognized the value of the warrants to be $15.0 million and reflected that amount in Receivables in installments. That value will be amortized into income on a level yield basis over the life of the underlying loans in accordance with SFAS 91. For quarters ended June 30, 2000 and September 30, 2000, $5.8 million and $1.6 million, respectively, was recognized as Amortization of finance income.
 
On July 1, 2000 we adopted SFAS 133, which classified the warrants as derivatives and requires them to be recorded in our financial statements at fair value. Quarterly adjustments to the warrants’ carrying value to reflect fair value are now charged to Other income. At September 30, 2000 the increase in the warrant’s fair market value was $15.0 million reflecting the consummation of Corvis’ initial public offering and the subsequent active trading of the stock. The total $30.0 million value of the warrants at that date is included on our balance sheet under Investments.
 
Note 5.    Other Assets
 
The following represents a summary of the major components of other assets:
 
(in thousands of dollars)
     September 30,
2000

     June 30,
2000

Unamortized debt issuance costs      $15,869      $12,613
Servicing assets         6,653         6,262
Prepaid expenses         4,988         6,096
Miscellaneous         5,139         5,669
  
    
          Total other assets      $32,649      $30,640
       
    

 

 
Note 6.    Reconciliation of Earnings per Share Calculation
 
(in thousands except per share data)
     Three Months Ended
September 30,

     2000
     1999
 
Basic
         
Income available to common shareholders      $  6,482      $  5,572
Average common shares      14,223      14,184
Basic earnings per common share      $    0.46      $    0.39
     
  
 
Diluted
         
Income available to common shareholders      $  6,482      $  5,572
Effect of dilutive securities:          
          Convertible debentures      184      184
     
  
Diluted income available to common shareholders      $  6,666      $  5,756
 
Average common shares       14,223       14,184
Effect of dilutive securities, net:          
          Warrants      11      10
          Options      291      244
          Convertible debentures      1,311      1,311
     
  
Diluted average common shares      15,836      15,749
Diluted earnings per common share      $    0.42      $    0.37
     
  
 
Note 7.    Segment Reporting
 
 In June 1999, we adopted SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information”. This statement establishes standards for the reporting of operating segments in interim and annual financial statements, as well as requiring related disclosures about products and services, geographic areas and major customers. In accordance with this standard, we have determined the following reportable segments based on the types of our financings:
 
·
Equipment financing, which includes:
 
·
Sophisticated medical equipment financing directly to U.S. and international end users,
·
Medical equipment contracts acquired from originators that generally do not have access to cost-effective permanent funding and
·
“Small ticket” equipment financing.
 
·
Medical receivables financing, which includes:
 
·
Medical receivable lines of credit issued to a wide variety of healthcare providers and
·
Software tracking of medical receivables.

 

 
·
Corporate and all other, which includes:

·
Interim real estate financing, mortgage loan placement, subordinated debt financing for assisted living facilities and, to a lesser extent, merger and acquisition advisory services to our customers operating in the long-term care, assisted care and specialized hospital markets;
·
Asset-backed financing (including lease lines of credit) to emerging growth companies and
·
Miscellaneous financial advisory services, corporate income and overhead allocations.
 
The following information reconciles our reportable segment information to consolidated totals:
 
(in thousands of dollars)
     Three Months Ended September 30, 2000
     Total Finance and
Other Income

     Interest
Expense

     Net
Earnings

     Net Financed
Assets

Equipment financing      $23,038      $17,069      $   249      $   859,824
Medical receivables financing          8,511          5,306        1,008            227,481
Corporate and all other        16,297            849        5,225             61,346
     
  
  

          Consolidated total      $47,846      $23,224      $6,482      $1,148,651
     
  
  
  
 
(in thousands of dollars)
     Three Months Ended September 30, 1999
     Total Finance and
Other Income

     Interest
Expense

     Net
Earnings

     Net Financed
Assets

Equipment financing      $20,459      $12,984      $3,398      $    817,507
Medical receivables financing          6,829          4,128           451            217,233
Corporate and all other         4,582             797        1,723              58,798
     
  
  
  
          Consolidated total      $31,870      $17,909      $5,572      $1,093,538
     
  
  
  
 

Monthly interest expense for warehouses and securitization debt are expensed to the divisions based upon the underlying collateral and advance rates. The interest expense for unsecured debt is charged according to the amount allocated on the balance sheet using the quarterly yield of unsecured debt. The balance sheet is allocated unsecured debt according to the percent of unsecured debt to the sum of the unsecured debt and shareholders’ equity at the consolidated level. Income taxes are allocated to each division using the best estimate of tax rates for that division.

 

Geographic Information

We attribute finance and other income earned and net financed assets to geographic areas based on the location of our subsidiaries. Finance and other income earned and the balances of net financed assets for the three month periods ended and as of September 30, 2000 and 1999 by geographic area are as follows:

Three Months Ended September 30, 2000

Total Finance and
Other income
Net Financed
Assets
(in thousands of dollars)

United States $ 39,495 $ 870,688
International 8,351     277,963

 
   Total $ 47,846   $ 1,148,651


 
Three Months Ended September 30, 1999

Total Finance and
 
Net Financed
(in thousands of dollars)
Other income
   
Assets

United States $ 25,848 $ 852,910
International 6,022 240,628

 
   Total $ 31,870 $ 1,093,538


Major Customer Information

We have no single customer that accounts for 10% or more of revenue for the three month periods ending September 30, 2000 and 1999.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

Results of Operations

Total equipment financing contracts originated and acquired were $164.5 million for the three month period ended September 30, 2000 compared with $211.3 million for the three month period ended September 30, 1999, a decrease of 22.2%. Included in the originations for the three month period ended September 30, 1999 was $22.5 million in contracts acquired through our joint venture in Singapore. In addition, our originations for the three months ended September 30, 1999 included $19.7 million in new business from DVI Capital, our wholesale leasing business division. The operations of this division were closed in March 2000.

Net financed assets totaled $1.1 billion at September 30, 2000, a decrease of $8.8 million or 0.8% down from the total as of June 30, 2000. Not included in net financed assets were the contracts sold but still serviced by us, which increased to $895.7 million as of September 30, 2000 compared to $877.7 million as of June 30, 2000, an increase of 2.1%. Managed net financed assets, the aggregate of those appearing on our balance sheet and those which have been sold and are still serviced by us, totaled $2.0 billion as of September 30, 2000, representing a 0.3% increase over the total as of June 30, 2000.

During the three month period ended September 30, 2000, new line of credit commitments in our medical receivables financing business were $19.5 million compared with $24.7 million for the same period of the prior fiscal year, a decrease of 21.1%. Net medical receivables funded at September 30, 2000 totaled $229.9 million, a decrease of $23.0 million or 9.1% down from the total as of June 30, 2000.

 

Total finance and other income increased 50.1% to $47.8 million for the three month period ended September 30, 2000 from $31.9 million for the three month period ended September 30, 1999. Finance income, excluding amortization of $1.6 million in Corvis deferred loan fees, was $29.2 million for the three month period ended September 30, 2000, or 9.6% of average net financed assets of $1.2 billion on an annualized basis. This compares to $24.4 million for the three month period ended September 30, 1999, which was an annualized 8.9% of average net financed assets of $1.1 billion. This 19.9% increase in finance income was largely due to the overall increase in the size of our loan portfolio. Other income increased 127.3% to $17.0 million for the three month period ended September 30, 2000 as compared to $7.5 million in the comparable prior year period. Other income for the three month period ended September 30, 2000 consists primarily of the recognition of the fair value of warrants to purchase the common stock of Corvis Corporation in the amount of $15.0 million (see note 4). Other income for the three months ended September 30, 1999 included $3.8 million related to warrants held in Cerent Corporation.

Interest expense was $23.2 million for the three month period ended September 30, 2000, or an 8.9% yield on average interest-bearing debt for that period on an annualized basis. This compares to $17.9 million of interest expense for the three month period ended September 30, 1999, which was an annualized 8.2% yield on average interest-bearing debt during that period. The $5.3 million increase in interest expense is mainly attributed to higher levels of debt necessary to finance a larger average portfolio. The Prime rate increased approximately 1.5% over the past year.

The net gain on sale of financing transactions decreased 44.8% to $4.0 million for the three month period ended September 30, 2000 compared to $7.2 million for the three month period ended September 30, 1999, representing 4.3% and 7.9% of the $93.3 million and $91.1 million in contracts sold during those periods. The decrease in gains during this period is due to volatility in the bond markets and widening spreads on asset-backed paper, as well as the recording of a provision for loss on recourse credit enhancements.

Selling, general and administrative expenses increased 42.6% to $12.5 million for the three month period ended September 30, 2000 from $8.7 million for the same quarter of the prior fiscal year. The increase is related primarily to higher compensation expense, legal costs related to the resolution of loan delinquencies, and the expansion and development of our international businesses.

The allowance for losses was $17.4 million at September 30, 2000, or 0.87% of our managed portfolio, compared to $13.5 million at September 30, 1999, or 0.75% of the managed portfolio at that time. We made provisions for losses on receivables for the three month period ended September 30, 2000 of $4.1 million, compared to $2.8 million for the same period ended September 30, 1999. In addition, we provided for our estimates of losses on recourse credit enhancements in the amount of $0.7 million. On a quarterly basis, we evaluate the collectibility of our receivables and record a provision for amounts deemed necessary to maintain an adequate allowance. Recoveries on receivables previously charged off were insignificant for the three month periods ended September 30, 2000 and 1999.

Earnings before minority interest, equity in net loss of investees and provision for income taxes increased 24.4% to $12.0 million for the three month period ended September 30, 2000 compared to $9.7 million for the same period ended September 30, 1999. Net earnings increased 16.3% to $6.5 million from $5.6 million in comparing the three month period ended September 30, 2000 to the same period ended September 30, 1999. Diluted earnings per share increased 13.5% to $0.42 from $0.37 when comparing the three month period ended September 30, 2000 to September 30, 1999. The increase in diluted earnings per share results from an increase in our net earnings, as the number of weighted average diluted shares outstanding changed only slightly between the periods.

Business Segments

Equipment Financing

In our equipment financing business, net financed assets increased $42.3 million to $859.8 million at September 30, 2000 from $817.5 million at September 30, 1999. However, this segment’s Net interest and other income decreased $1.5 million during the quarter ended September 30, 2000 due to a combination of increasing interest rates and lower levels of Other income. Net earnings for the three months ended September 30, 2000 were $0.2 million compared with $3.4 million for the three months ended September 30, 1999 resulting from lower Net interest and other income, a lower gain on sale, an increase in selling, general and administrative expenses and our inability to deduct losses in certain foreign countries. Gain on sale

decreased $2.1 million due to volatility in the bond markets and widening spreads on asset-backed paper. Selling, general and administrative expenses increased $1.6 million due to higher compensation expense, legal costs related to the resolution of loan delinquencies, and the expansion and development of our international businesses. Our tax expense would have been $0.3 million lower if we were allowed to deduct losses of foreign operations.

Medical Receivables Financing

In our medical receivables financing business, net financed assets at September 30, 2000 were $227.5 million, an increase of $10.3 million over the amount at September 30, 1999. The average portfolio outstanding during the quarter, however, was substantially higher, resulting in increased Net interest and other income and increased net earnings for the quarter ended September 30, 2000.

Corporate and all other

Total finance and other income increased $11.7 million mainly due to the inclusion of $15.0 million in Other income related to the recognition of the fair value of warrants to purchase the common stock of Corvis Corporation. Other income for the three months ended September 30, 1999 included $3.8 million related to warrants held in Cerent Corporation. Gain on sale decreased $1.1 million mostly due to the recording of a provision for loss on recourse credit enhancements at September 30, 2000. Selling, general and administrative expenses increased $2.1 million due to higher compensation expense. The provision for losses on receivables increased $2.0 million reflecting management’s continued review and assessment of possible losses on contract receivables, along with the growth in our managed net financed assets. The increased provision expense is not reflected in our Equipment Financing and Medical Receivables Financing segments until the time of actual charge-off. The provision for taxes includes an adjustment of $0.4 million to retroactively reflect an increase in state taxes resulting from a greater portion of our business being conducted in states with higher tax rates.

Financial Condition

Total shareholders’ equity increased $3.7 million to $219.1 million at September 30, 2000 from $215.4 million at June 30, 2000. The increase was primarily due to net earnings of $6.5 million, offset by cumulative foreign currency translation adjustments of $1.2 million and unrealized loss on derivative instruments designated as cash flow hedges of $1.6 million.

At September 30, 2000, we had available an aggregate of $697.4 million in warehouse facilities of which $373.8 million was utilized.

We believe that our present warehouse and permanent funding sources are sufficient to fund our current needs for our equipment and medical receivables financing businesses.

Through September 30, 2000, we have completed 26 securitizations for medical equipment and medical receivables financings totaling approximately $2.9 billion, consisting of public debt issues totaling $1.2 billion and private placements of debt and contract sales totaling $1.7 billion. We expect to continue to use securitization (on both a public and private basis) or other structured finance transactions as our principal means to permanently fund our contracts for the foreseeable future.

 
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
We are exposed to two primary types of market risk: interest rate risk and foreign currency exchange risk. We actively manage both of these risks.
 
Interest Rate Risk
 
The majority of our assets and liabilities are financial contracts with fixed and variable rates. Any mismatch between the repricing and maturity characteristics of our assets and liabilities exposes us to interest rate risk when interest rates fluctuate. For example, our equipment loans are structured and permanently funded on a fixed-rate basis, but we use warehouse facilities until the permanent matched funding is obtained. Since funds borrowed through warehouse facilities are obtained on a floating-rate basis, we are exposed to a certain degree of risk if interest rates rise and increase our borrowing costs. In addition, when we originate equipment loans, we base our pricing in part on the spread we expect to achieve between the interest rate we charge our equipment loan customers and the effective interest cost we will pay when we permanently fund those loans. Increases in interest rates that increase our permanent funding costs between the time the loans are originated and the time they are permanently funded could narrow, eliminate or even reverse this spread. In addition, changes in interest rates affect the fair market value of fixed rate assets and liabilities. In a rising interest rate environment, fixed rate assets lose market value whereas fixed rate liabilities gain market value and vice versa.
 
To manage our interest rate risk, we employ a hedging strategy using derivative financial instruments such as forward rate agreements, Treasury locks, forward start swap and interest rate swaps, caps and collars. We do not use derivative financial instruments for trading or speculative purposes. We manage the credit risk of possible counterparty default in these derivative transactions by dealing exclusively with counterparties with investment grade ratings.
 
Before entering into a derivative transaction for hedging purposes, we determine that a high degree of initial effectiveness exists between the change in the value of the hedged item and the change in the value of the derivative from a movement in interest rates. High effectiveness means that the change in the value of the derivative will be effectively offset by the change in the value of the hedged asset or liability. We measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness, as defined by SFAS 133, is recognized in the income statement.
 
There can be no assurance that our hedging strategies or techniques will be effective, that our profitability will not be adversely affected during any period of change in interest rates or that the costs of hedging will not exceed the benefits.
 

The following table provides information about certain financial instruments held that are sensitive to changes in interest rates. For assets and liabilities, the table presents principal cash flows and related weighted average interest rates by expected maturity date at September 30, 2000. For derivative financial instruments, the table presents notional amounts and weighted average interest rates by expected (contractual) maturity dates. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract. Weighted average variable rates, which are generally LIBOR-based, represent the interest rates in effect at September 30, 2000. The information is presented in U.S. dollar equivalents, which is our reporting currency. The actual cash flows are denominated in U.S. dollars (US), Singapore dollars (SGD), Japanese yen (JPY), Australian dollars (AUD), British pounds (GBP) and Euro (EUR), as indicated in parentheses. The table excludes investments in direct financing leases totaling $321.5 million in accordance with disclosure requirements, although our lease contracts are exposed to interest rate risk. The information does not include any estimates for prepayments, reinvestment, refinancing or credit losses.

 

 
        Expected Maturity Date–Qtr Ended September 30,
     There-
after

     Total
     Fair
Value

(in thousands of dollars)
      2001
      2002
      2003
      2004
      2005
Rate-Sensitive Assets:                                        
             
Fixed rate receivables in
        installments (US)
  $  90,543     $    57,997     $   39,246     $   28,797     $   18,100       
$
18,859        $ 253,542        $ 245,474  
    Average interest rate      9.82 %      9.74 %      9.84 %      9.70 %      9.77 %     
9.55 %      9.82 %       
                                           
                   
Fixed rate receivables in
        installments (SGD)
  $     1,135      450     $    500     $     557     $    296       
       $     2,938        $     2,853  
    Average interest rate        10.29 %        10.68 %        10.68 %        10.68 %        10.68 %     
         10.29 %       
                                           
                   
Fixed rate receivables in
        installments (JPY)
  $    3,369     $    3,558      2,892     $   1,870      511       
       $   12,200        $   11,046  
    Average interest rate        6.03 %        6.03 %        6.03 %        6.03 %        6.75 %     
         6.03 %       
                                           
                   
Fixed rate receivables in
        installments (AUD)
  $   410     $   182      59     $    52      131       
       $       834        $       771  
    Average interest rate        8.77 %        8.70 %        8.77 %        8.59 %        8.59 %     
         8.77 %       
                                           
                   
Fixed rate receivables in
        installments (GBP)
  $     61     $    55      61     $   5                
       $       182        $       177  
    Average interest rate        10.88 %        10.88 %        10.88 %        10.88 %              
         10.88 %       
                                           
                   
Fixed rate receivables in
        installments (EUR)
  $  7,083     $    5,355     $   4,423      $    4,594      3,201       
$
  2,866        $   27,522        $   25,625  
     Average interest rate        8.23 %        8.35 %        8.42 %        8.49 %        8.74 %     
9.35 %        8.23 %       
                                           
                   
Floating rate receivables in
        installments (US)
  $    55,738     30,919     18,269      $ 14,941          2,353       
$
  1,291        $ 123,511        $ 123,511  
     Average interest rate        9.44 %        9.35 %        9.37 %        9.97 %        9.32 %     
9.87 %        9.44 %       
                                           
                   
Floating rate notes collateralized by
        medical receivables (US)
  $   173,196     $   47,268     $ 10,223      $  4,945                
       $ 235,632        $ 235,632  
     Average interest rate        11.44 %        11.13 %        10.78 %        11.00 %              
         11.44 %       
                                           
                   
Fixed rate recourse credit
        enhancements (US)
     11,045     $    11,499     $   13,209      $   7,537      2,961       
$
    599        $   46,850        $   45,060  
     Average interest rate        7.06 %        7.05 %        7.00 %        7.37 %        7.55 %     
7.55 %        7.06 %       
    
    
    
    
    
     

     
     
  
                    Totals   $   342,580     $ 157,283     88,882      $   63,298     $ 27,553       
$
23,615        $ 703,211        $ 690,149  
    
    
    
    
    
     
     
     
  
          Average interest  rate        10.42 %        9.76 %        9.24 %        9.40 %        9.32 %     
9.49 %        9.99 %       
    
    
    
    
    
     

     
             
                                           
                 
Derivatives Matched Against Assets:
                                       
             
                                           
                 
Interest Rate Swaps                                                        
Pay variable rate swaps (US)   $  5,000                                                     $     5,000        $         (38 )
     Weighted average pay rate        7.01 %                                                     7.01 %       
     Weighted average receive rate        5.83 %                                                     5.83 %       
                                                                 
Pay fixed rate swaps (AUD)   $   981                                $ 1,830                 $     2,811        $           2  
     Weighted average pay rate        5.56 %                                   6.64 %                 6.26 %       
     Weighted average receive rate        6.34 %                                   6.39 %                 6.37 %       
                                                                 
Pay fixed rate swaps (EUR)                               $    7,727                          $     7,727        $         30  
     Weighted average pay rate                                   5.18 %                          5.18 %       
     Weighted average receive rate                                   4.75 %                          4.75 %       
    
              
    
               
     
  
          Totals   $   5,981                    $    7,727     $     1,830               $   15,538        $           (6 )
    
              
    
             
     
  

 

 

 

 
       Expected Maturity Date–Qtr Ended September 30,
     There–
after

     Total
     Fair Value
(in thousands of dollars)

     2001
     2002
     2003
     2004
     2005
Rate-Sensitive Liabilities:     
    
    
    
    
    
    
    
   
     
     
     
     
     
     
     
 
Variable rate borrowings
        under warehouse facilities (US)
    
$
294,466       
      
      
      
      
      
$
    294,466       
$
    294,466
     Average interest rate     
8.27 %     
      
      
      
      
      
8.27 %     
   
     
     
     
     
     
     
     
 
Variable rate borrowings
        under warehouse facilities (AUD)
    
$
 4,016       
      
      
      
      
      
$
        4,016       
$
        4,016
     Average interest rate     
7.83 %     
      
      
      
      
      
7.83 %     
   
     
     
     
     
     
     
     
 
Variable rate borrowings
        under warehouse facilities (GBP)
    
$
13,415       
      
      
      
      
      
$
      13,415       
$
      13,415
     Average interest rate     
7.42 %     
      
      
      
      
      
7.42 %     
   
     
     
     
     
     
     
     
 
Variable rate borrowings
        under warehouse facilities (JPY)
    
$
  26,082       
      
      
      
      
      
$
      26,082       
$
      26,082
     Average interest rate     
2.87 %     
      
      
      
      
      
2.87 %     
   
     
     
     
     
     
     
     
 
Variable rate borrowings
        under warehouse facilities (SGD)
    
$
     7,258       
      
      
      
      
      
$
        7,258       
$
        7,258
     Average interest rate     
5.15 %     
      
      
      
      
      
5.15 %     
   
     
     
     
     
     
     
     
 
Variable rate borrowings
        under warehouse facilities (EUR)
    
$
 28,562       
      
      
      
      
      
$
      28,562       
$
      28,562
     Average interest rate     
5.78 %     
      
      
      
      
      
5.78 %     
   
     
     
     
     
     
     
     
 
Fixed rate discounted
        receivables (US)
    
$
 81,942       
$
   62,948       
$
        44,564       
$
        26,541       
$
       9,002       
$
     1,815       
$
    226,812       
$
    226,877
     Average interest rate     
6.94 %     
7.06 %     
7.21 %     
7.41 %     
7.49 %     
7.75 %     
6.94 %     
   
     
     
     
     
     
     
     
 
Variable rate discounted
        receivables (US)
    
       91,258       
$
     14,641       
$
        99,886       
$
          9,687       
$
       8,656       
      
$
    224,128       
$
    224,128
     Average interest rate     
7.94 %     
10.18 %     
7.86 %     
10.18 %     
10.18 %     
      
8.23 %     
   
     
     
     
     
     
     
     
 
Senior notes (US)     
      
      
      
$
     155,000       
      
      
$
    155,000       
$
    140,500
     Average interest rate     
      
      
      
9.88 %     
      
      
9.88 %     
   
     
     
     
     
     
     
     
 
Other debt (US)     
$
     13,598       
$
      10,806       
$
          9,667       
$
          2,000       
$
     27,000       
      
$
      63,071       
$
      62,951
     Average interest rate     
9.45 %     
9.69 %     
9.79 %     
8.34 %     
9.58 %     
      
9.56 %     
   
     
     
     
     
     
     
     
 
Other debt (GBP)     
$
   1,099       
$
      1,077       
$
             915       
$
             351       
$
           277       
$
     1,010       
$
        4,729       
$
        4,214
     Average interest rate     
8.03 %     
8.08 %     
8.33 %     
8.07 %     
8.07 %     
7.56 %     
8.01 %     
   
     
     
     
     
     
     
     
 
Convertible sub notes (US)     
      
$
 13,900       
      
      
      
      
$
      13,900       
$
      25,488
     Average interest rate     
      
9.13 %     
      
      
      
      
9.13 %     
     
     
     
     
     
     
     
     
          Totals     
$
     561,696       
$
 103,372       
$
     155,032       
$
     193,579       
$
     44,935       
$
     2,825       
$
1,061,439       
$
1,057,957
     
     
     
     
     
     
     
     
          Average interest  rate
   
   7.61 %
   
   8.07 %
  
    7.80 %
    
  9.54 %
   
   9.27 %
   
   7.68 %
    
  8.07 %     
       
     
     
     
     
     
     
          

 

 
    Expected Maturity  Date – Qtr   Ended September 30,
  There-
            Fair
 
(in thousands of dollars)
  2001
    2002
  2003
  2004
  2005
  after
    Total
  Value
 
           
             
                 
Derivatives Matched Against Liabilities:          
             
                 
         
             
                 
Interest Rate Swaps          
             
                 
         
             
                 
Pay fixed rate swaps (US)      $ 247,577       
            $   8,000
    
       $ 255,577      $ (1,704 )
    Weighted average pay rate      7.10 %     
                 5.84
 %    
       7.06  %    
    Weighted average receive rate      6.74 %     
                 6.76
% 
       6.74  %     
Pay fixed rate swaps (JPY)      $  3,417       
                
    
       $  3,417      $  2  
    Weighted average pay rate      0.47 %     
                
    
       0.47  %    
    Weighted average receive rate      0.40 %     
                
    
       0.40  %       
Pay fixed rate swaps (EUR)      $  8,827       
                
    
       $  8,827      $  34  
    Weighted average pay rate      4.35 %     
                
    
       4.35  %      
    Weighted average receive rate      4.68 %     
                
    
       4.68  %      
                                                   
Treasury Locks (US)      $  50,000       
                
    
       $ 50,000      $  (979 )
    Average strike rate      6.87 %     
                
    
       6.87  %      
    Average index rate      5.96 %     
                
    
       5.96  %       
                                                   
Interest Rate Caps (US)      $  40,000        $ 50,000
 
                
    
       $ 90,000      $  –  
    Average strike rate      6.38 %      6.87
%
                
    
       6.65  %       
    Average index rate      6.62 %      6.62
%
                
    
       6.62  %     
  
     
  
              
  
        
  
        Totals      $ 349,821        $ 50,000
 
          $  8,000
    
     $ 407,821      $ (2,647 )
     
     
  
              
  
        
  
 
Comparison to Prior Year
 
The following table provides information about certain financial instruments held that are sensitive to changes in interest rates. For assets and liabilities, the table presents principal cash flows and related weighted average interest rates by expected maturity date at September 30, 1999. For derivative financial instruments, the table presents notional amounts and weighted average interest rates by expected (contractual) maturity dates. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract. Weighted average variable rates, which are generally LIBOR-based, represent the interest rates in effect at September 30, 1999. The information is presented in U.S. dollar equivalents, which is our reporting currency. The actual cash flows are denominated in US dollars (US), Euro (EUR), Singapore dollars (SGD), Japanese Yen (JPY), Australian dollars (AUD) and British pounds (GBP), as indicated in parentheses. The table excludes investments in direct financing leases in accordance with disclosure requirements, although our lease contracts are exposed to interest rate risk. The information does not include any estimates for prepayments, reinvestment, refinancing or credit losses.

 

 
 
       Expected Maturity Date—Qtr. Ended September 30,
     There-
after

     Total
     Fair Value
(in thousands of dollars)

     2000
     2001
     2002
     2003
     2004
Rate-Sensitive Assets:                                        
Fixed rate receivables in
     installments (US)
     $  81,347        $  62,065        $50,039        $30,731        $20,136        $15,514        $259,832        $252,777  
   Average interest  rate      9.87 %      9.89 %      9.94 %      9.96 %      9.88 %      9.83 %      9.87 %     
                                                 
Fixed rate receivables in
     installments (EUR)
     $    3,249        $    3,867        $  3,250        $  1,948        $  2,004        $  2,733        $  17,051        $  15,655  
    Average interest  rate      8.75 %      9.12 %      9.35 %      9.42 %      9.45 %      9.38 %      8.75 %     
                                                 
Fixed rate receivables in
     installments (SGD)
     $       881        $      431        $    479        $     533        $     577        $     306        $    3,207        $    3,076  
   Average interest  rate      10.78 %      10.78 %      10.78 %      10.78 %      10.71 %      10.68 %      10.78 %     
                                                 
Fixed rate receivables in
     installments (JPY)
     $     3,486        $    1,365        $  1,441        $  1,521        $     659        -        $    8,472        $    7,512  
   Average interest  rate      5.63 %      5.44 %      5.44 %      5.44 %      5.44 %      -        5.63 %     
                                                 
Fixed rate receivables in
     installments (AUD)
     $        471        $      339        $    145        $        1        -        -        $      956        $      851  
   Average interest  rate      10.41 %      10.39 %      10.36 %      10.25 %      -        -        10.41 %     
                                                 
Fixed rate receivables in
     installments (GBP)
     $          82        $        55        $      61        $      68        $         5        -        $      271        $      265  
   Average interest  rate      9.27 %      10.88 %      10.88 %      10.88 %      10.88 %      -        9.27 %     
                                                 
Floating rate receivables in
     installments (US)
     $   55,374        $  33,576        $22,067        $14,571        $ 10,051        $    615        $136,254        $136,254  
   Average interest  rate      8.51 %      7.90 %      7.50 %      8.11 %      9.53 %      6.40 %      8.51 %     
                                                 
Floating rate notes collateralized by
     medical receivables  (US)
     $ 120,207        $  94,400        $  4,601        $  5,753        -        -        $224,961        $224,961  
   Average interest  rate      10.41 %      10.39 %      10.36 %      10.25 %      -        -        10.41 %     
                                                 
Fixed rate recourse credit
enhancements  (US)
     $  13,663        $  11,266        $10,391        $12,813        $  6,057        $  1,576        $  55,766        $  51,602  
     Average interest  rate      6.72 %      6.76 %      6.72 %      6.70 %      6.93 %      7.01 %      6.72 %     
     
     
     
     
     
     
     
     
  
          Totals      $278,760        $207,364        $92,474        $67,939        $ 39,489        $20,744        $706,770        $692,953  
     
     
     
     
     
     
     
     
  
          Average interest  rate      9.62 %      9.58 %      8.93 %      8.86 %      9.25 %      9.47 %      9.46 %     
     
     
     
     
     
     
     
           
                                             
Derivatives Matched Against Assets:                                        
                                             
Interest Rate Swaps                                        
                                                 
Pay variable rate swaps (US)      -        -        $  5,000        -        -        -        $    5,000        $      (27 )
          Weighted average  pay rate      -        -        5.58 %      -        -        -        5.58 %     
          Weighted average  receive rate      -        -        5.83 %      -        -        -        5.83 %     

 
 
(in thousands of dollars)
     Expected Maturity Date–Qtr. Ended September 30,
     There-
after

     Total
     Fair
Value

     2000
     2001
     2002
     2003
     2004
Rate-Sensitive Liabilities:                         
 
                                               
Variable rate borrowings under
      warehouse facilities (US)
     $312,244                                           $312,244        $312,244
          Average interest  rate      6.87 %                                         6.87 %     
 
Variable rate borrowings under
     warehouse facilities (AUD)
     $    2,034                                             $    2,034        $    2,034
          Average interest  rate      6.16 %                                         6.16 %     
 
Variable rate borrowings under
     warehouse facilities (EUR)
     $    9,123                                           $    9,123        $    9,123
          Average interest  rate      4.09 %                                         4.09 %     
 
Variable rate borrowings under
     warehouse facilities (GBP)
            $    9,098                                    $    9,098        $    9,098
          Average interest rate             7.33 %                                  7.33 %     
 
Variable rate borrowings under
     warehouse facilities (JPY)
     $  11,724                                           $  11,724        $  11,724
          Average interest rate      3.13 %                                         3.13 %     
 
Variable rate borrowings under
     warehouse facilities (SGD)
     $    5,876                                           $    5,876        $    5,876
          Average interest rate      5.39 %                                         5.39 %     
 
Fixed rate discounted
      receivables (US)
     $  83,626        $  54,365        $33,129        $18,246        $    5,181        $    334        $194,881        $192,899
          Average interest rate      6.80 %      6.38 %      6.37 %      6.41 %      6.51 %      6.24 %      6.80 %     
 
Variable rate discounted
     receivables (US)
     $  25,000        $  75,000                                    $100,000        $100,000
          Average interest rate      7.61 %      6.32 %                                  6.64 %     
 
Senior notes (US)                                  $155,000               $155,000        $151,625
          Average interest rate                                  9.88 %             9.88 %     
 
Other debt (US)      $  18,762        $  10,603        $  6,370        $11,003        $    2,000        $25,000        $  73,738        $  67,399
          Average interest rate      7.55 %      7.90 %      8.36 %      7.57 %      8.34 %      7.85 %      7.80 %     
 
Other debt (GBP)      $       692        $       740        $     651        $     429                      $    2,512        $    2,467
          Average interest rate      8.13 %      8.13 %      8.22 %      9.10 %                    8.32 %     
 
Convertible subordinated
     notes (US)
                   $13,900                             $  13,900        $  21,473
          Average interest rate                    9.13 %                           9.13 %     
   
   
   
   
   
   
   
   
                 Totals      $469,081        $149,806        $54,050        $29,678        $162,181        $25,334        $890,130        $885,962
   
   
   
   
   
   
   
   
          Average interest rate      6.76 %      6.52 %      7.34 %      6.88 %      9.75 %      7.83 %      7.39 %     
     
     
     
     
     
     
     
     

 

 
    Expected Maturity Date—Qtr. Ended September 30,
                       
(in thousands of dollars)
  2000
    2001
  2002
    2003
  2004
  There-
after

    Total
   
Fair
Value

 
Derivatives Matched Against Liabilities:                                                  
Interest Rate Swaps                                                  
                                                     
Pay fixed rate swaps (US)        -        -        -        -      -      $ 10,000        $   10,000        $    85  
       Weighted average pay rate        -        -        -        -      -        5.84 %        5.84 %       
       Weighted average receive  rate        -        -        -        -      -        5.06 %        5.06 %       
                                                     
Pay fixed rate swaps  (AUD)        -        -      $ 2,366        -      -        -        $     2,366        $       3  
       Weighted average pay rate        -        -        5.56 %             -             -        -          5.56 %       
       Weighted average receive  rate        -        -   4.93 %      -      -        -          4.93 %       
                                                     
Treasury Locks (US)      $ 300,000        -        -        -      -        -        $ 300,000        $ (884 )
       Average strike rate        5.85 %              -        -        -      -        -          5.85 %       
       Average index rate        5.67 %      -        -        -      -        -          5.67 %       
     
           
                 
     
     
  
Totals      $ 300,000             $ 2,366                  $ 10,000        $ 312,366        $ (796 )
     
           
                 
     
     
  
 
There were no material changes in rate-sensitive assets from the prior year.
 
Total rate-sensitive liabilities increased $171.3 million from the prior year. This increase was primarily due to the completion of a $100.0 million medical receivables securitization and an $80.0 million international equipment securitization.
 
Changes in the overall derivative positions held at September 30, 2000 and 1999 reflect the changes in the Company’s exposures in its financial contracts.
 
Foreign Currency Exchange Rate Risk
 

We have foreign currency exposures in our international operations due to lending in some areas in local currencies. As a general practice, we have not hedged the foreign exchange exposure related to either the translation of overseas earnings into U.S. dollars or the translation of overseas equity positions back to U.S. dollars. Our preferred method for minimizing foreign currency transaction exposure is to fund local currency assets with local currency borrowings. For specific local currency-denominated receivables or for a portfolio of local currency-denominated receivables for a specific period of time, hedging with derivative financial instruments may be necessary to manage the foreign currency exposure derived from funding in U.S. dollars. The types of derivative instruments used are foreign exchange forward contracts and cross-currency interest rate swaps.

 

 
The following table provides information about certain financial instruments held that are sensitive to changes in foreign exchange rates. For assets and liabilities, the table presents principal cash flows and related weighted average interest rates by expected maturity date at September 30, 2000. For foreign currency forward exchange agreements, the table presents notional amounts and weighted average exchange rates by contractual maturity dates. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract. The information is presented in U.S. dollar equivalents, which is our reporting currency. The actual cash flows are denominated in Singapore dollars (SGD), Japanese yen (JPY), Australian dollars (AUD), British pounds (GBP) and Euro (EUR), as indicated in parentheses. The table excludes investments in direct financing leases totaling $98.6 million in accordance with disclosure requirements, although our lease contracts are exposed to foreign currency rate risk. The information does not include any estimates for prepayments, reinvestment, refinancing or credit losses.
 
     Expected Maturity Date–Qtr Ended September 30,
     There-
after

     Total
     Fair
Value

(in thousands of dollars) 
 
   2001
       2002
     2003
     2004
     2005
Foreign Currency Sensitive Assets:
                                                   
Fixed rate receivables in
          installments (SGD)
   $   1,135       
$
  450     
$
  500       
$
  557       
$
  296                 $   2,938       
$
  2,853  
     Average interest rate      10.29 %     
10.68%     
10.68 %     
10.68 %     
10.68 %                 10.29 %     
                                                               
Fixed rate receivables in 
          installments (JPY)
   $   3,369       
$
3,558     
$
2,892       
$
1,870       
$
  511                 $ 12,200       
$
11,046  
     Average interest rate      6.03 %     
6.03%     
6.03 %     
6.03 %     
6.75 %                 6.03 %     
                                                               
Fixed rate receivables in
           installments (AUD)
   $     410       
$
  182     
$
    59       
$
    52       
$
  131                 $     834       
$
    771  
     Average interest rate      8.77 %     
8.70%     
8.77 %     
8.59 %     
8.59 %                 8.77 %     
                                                               
Fixed rate receivables in
          installments (GBP)
   $       61       
$
55     
$
    61       
$
      5       
                $     182       
$
    177  
     Average interest rate      10.88 %     
10.88%     
10.88 %     
10.88 %     
                  10.88 %     
                                                               
Fixed rate receivables in
          installments (EUR)
   $   7,083       
$
5,355     
$
4,423       
$
4,594       
$
3,201       
$
2,866        $ 27,522       
$
25,625  
     Average interest rate      8.23 %     
8.35%        8.42 %        8.49 %     
8.74 %        9.35 %        8.23 %     
    
     
  
     
     
    
     
     
  
         Totals    $ 12,058       
$
9,600     
$
7,935       
$
7,078       
$
4,139       
$
2,866        $ 43,676       
$
40,472  
    
     
  
     
     
    
     
     
  
         Average interest  rate      7.84 %        7.62%        7.71 %        8.01 %        8.63 %        9.35 %        7.78 %       
    
     
  
     
     
    
     
          
Derivatives Matched Against Assets:
                                                     
Foreign Exchange Agreements                                                      
Receive US$ / Pay EUR   
$
11,311                                             
    
$ 11,311       
$
      (61 )
     Avg. contractual exchange  rate      0.88                                                     0.88         

 

 
 
       Expected Maturity Date–Qtr Ended September 30,
    
(in thousands of dollars)
     2001
     2002
     2003
     2004
     2005
     There–
after

     Total
     Fair
Value

Foreign Currency Sensitive Liabilities:
 
 
  Variable rate borrowings under
      warehouse facilities (AUD)
  
$
4,016
 
  
 
  
 
  
 
  
 
          $
4,016
     $
4,016
 
    Average interest rate     
7.83
%
    
 
    
 
    
 
    
 
               
7.83
 %       
 
  Variable rate borrowings under
      warehouse facilities (GBP)
  
$
13,415
 
  
 
  
 
  
 
  
 
          $
13,415
     $
13,415
 
    Average interest rate     
7.42
%
    
 
    
 
    
 
    
 
                7.42  %       
 
   Variable rate borrowings under
      warehouse facilities (JPY)
  
$
26,082
 
  
 
  
 
  
 
  
 
          $ 26,082      $
26,082
 
    Average interest rate     
2.87
%
    
 
    
    
 
    
 
                2.87  %       
 
  Variable rate borrowings under 
      warehouse facilities (SGD)
$
7,258
$
7,258
$
7,258
    Average interest rate     
5.15
%
    
 
    
 
    
 
    
 
                5.15 %
 
  Variable rate borrowings under
      warehouse facilities (EUR)
$
28,562
$ 28,562 $
28,562
    Average interest rate     
5.78
%
    
 
    
 
    
 
    
 
                5.78 %
 
Other debt (GBP)     
$
    1,099
 
    
$
    1,077
 
    
$
915
 
    
$
351
 
    
$
277
 
     $ 1,010        $     4,729       
   4,214
 
    Average interest rate     
8.03
%
    
8.08
%
    
8.33
%
    
8.07
%
    
8.07
%
       7.56 %        8.01 %
 








            Totals     
$
  80,432
 
    
$
    1,077
 
    
$
915
 
    
$
351
 
    
$
277
 
     $ 1,010        $   84,062        $
  83,547
 
 








            Average interest rate     
5.19
%
    
8.08
%
    
8.33
%
    
8.07
%
    
8.07
%
       7.56 %        5.31 %
 







 
Comparison to Prior Year
 

The following table provides information about certain financial instruments held that are sensitive to changes in foreign exchange rates. For assets and liabilities, the table presents principal cash flows and related weighted average interest rates by expected maturity date at September 30, 1999. For foreign currency forward exchange agreements, the table presents notional amounts and weighted average exchange rates by contractual maturity dates. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract. The information is presented in U.S. dollar equivalents, which is our reporting currency. The actual cash flows are denominated in Euros (EUR), Singapore dollars (SGD), Japanese yen (JPY), Australian dollars (AUD) and British pounds (GBP), as indicated in parentheses. The table excludes investments in direct financing leases in accordance with disclosure requirements, although our lease contracts are exposed to foreign currency rate risk. The information does not include any estimates for prepayments, reinvestment, refinancing or credit losses.

 

 

 

 
       Expected Maturity Date–Qtr. Ended September 30,
     There-
after

     Total
     Fair
Value

(in thousands of dollars)

     2000
     2001
     2002
     2003
     2004
Foreign Currency Sensitive Assets:                                        
                                                                 
Fixed rate receivables in
     installments (EUR)
     $ 3,249        $ 3,867        $ 3,250        $ 1,948        $ 2,004        $ 2,733        $ 17,051        $ 15,655  
   Average interest rate        8.75 %        9.12 %        9.35 %        9.42 %        9.45 %        9.38 %        8.75 %     
                                                                 
Fixed rate receivables in
     installments (SGD)
     $   881        $   431        $   479        $   533        $   577        $   306        $   3,207        $   3,076  
   Average interest rate        10.78 %        10.78 %        10.78 %        10.78 %        10.71 %        10.68 %        10.78 %     
                                                                 
Fixed rate receivables in
     installments (JPY)
     $ 3,486        $ 1,365        $ 1,441        $ 1,521        $   659                 $   8,472        $   7,512  
   Average interest rate        5.63 %        5.44 %        5.44 %        5.44 %        5.44 %                 5.63 %     
                                                                 
Fixed rate receivables in
     installments (AUD)
     $ 471        $ 339        $ 145        $ 1                          $     956        $ 851  
   Average interest rate        10.41 %        10.39 %        10.36 %        10.25 %                          10.41 %     
                                                                 
Fixed rate receivables in
     installments (GBP)
     $ 82        $ 55        $ 61        $ 68        $ 5                 $ 271        $ 265  
   Average interest rate        9.27 %        10.88 %        10.88 %        10.88 %        10.88 %                 9.27 %     
     
  
     
     
     
     
     
     
  
             Totals      $ 8,169        $ 6,057        $ 5,376        $ 4,071        $ 3,245        $ 3,039        $ 29,957        $ 27,359  
     
  
     
     
     
     
     
     
  
             Average interest rate        7.74 %        8.50 %        8.47 %        8.14 %        8.86 %        9.51 %        8.14 %     
     
     
     
     
     
     
     
          
Derivatives Matched Against Assets:                                        
                 
Foreign Exchange Agreements                                        
               
Receive US$ / Pay EUR      $ 7,871                                                     $   7,871        $     (133 )
   Avg. contractual exchange rate        1.06                                                       1.06       

     Expected Maturity Date–Qtr. Ended September 30,
   There-
after

   Total
   Fair
Value

     2000
   2001
   2002
   2003
   2004
(in thousands of dollars)   
Foreign Currency Sensitive Liabilities:                        
Variable rate borrowings under
     warehouse facilities (EUR)
   $ 9,123      –        –        –        –      –      $   9,123      $  9,123
  Average interest rate    4.09 %    –        –        –        –      –      4.09 %   
   
Variable rate borrowings under
     warehouse facilities (AUD)
   $ 2,034      –        –        –        –      –      $   2,034      $   2,034
  Average interest rate    6.16 %    –        –        –        –      –      6.16 %   
   
Variable rate borrowings under
     warehouse facilities (GBP)
   –        $ 9,098      –        –        –      –      $   9,098      $   9,098
  Average interest rate    –        7.33 %    –        –        –      –      7.33 %   
   
Variable rate borrowings under
     warehouse facilities (JPY)
   $11,724      –        –        –        –      –      $ 11,724      $ 11,724
  Average interest rate    3.13 %    –        –        –        –      –      3.13 %   
   
Variable rate borrowings under
     warehouse facilities (SGD)
   $  5,876      –        –        –        –      –      $    5,876      $   5,876
  Average interest rate    5.39 %    –        –        –        –      –      5.39 %   
   
Other debt (GBP)    $     692      $     740      $651      $429      –      –      $    2,512      $   2,467
  Average interest rate    8.13 %    8.13 %    8.22 %    9.10 %    –      –      8.32 %   
    
     
     
     
                 
     
      Totals    $29,449      $  9,838      $651      $429            $  40,367      $  40,322
    
     
     
     
           
     
      Average interest rate    4.20 %    7.39 %    8.22 %    9.10 %          5.10 %   
    
     
     
     
           
     
 
Total foreign currency sensitive assets increased $13.7 million from the prior year due to the growth in our international portfolio.
 
Total foreign currency sensitive liabilities increased $43.7 million from the prior year due to new international borrowing facilities.
 
The current and prior year derivative positions are forward sales of currencies to hedge foreign currency denominated assets funded on a short-term basis with U.S. dollars.
 
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
 
 Any statements contained in this Form 10-Q that are not historical facts are forward-looking statements; and, therefore, many important factors could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, changes (legislative and otherwise) in the healthcare industry, those relating to demand for our services, pricing, market acceptance, the effect of economic conditions, litigation, competitive products and services, the results of financing efforts, the ability to complete transactions, and other risks identified in our Securities and Exchange Commission filings.

 

 
 
PART II—OTHER INFORMATION
 
Items 1 through 5 have been omitted because the related information is either inapplicable or has been previously reported.
 
ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K
 
(a) Exhibits
 
          27.   Financial Data Schedule
 
(b) Form 8-K
 
          None

 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
   
        DVI, INC.

        (Registrant)
     
Date: November 13, 2000    
By       /s/    MICHAEL A. O’HANLON         
Michael A. O’Hanlon
President and Chief Executive Officer
   
Date: November 13, 2000    
By       /s/    STEVEN R. GARFINKEL    
Steven R. Garfinkel
Executive Vice President and Chief Financial Officer
 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission